Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?-Reference-Cited by-同舟云学术

Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?

Published:2016-09-23 Issue:4 Volume:27 Page:559-569
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Bournia Vasiliki-Kalliopi¹,Kitas George¹,Protogerou Athanasios D.¹,Sfikakis Petros P.¹

Affiliation:

1. First Department of Propaedeutic and Internal Medicine and Joined Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2016.1232332

Reference103 articles.

1. Atherosclerosis in Rheumatoid Arthritis Versus Diabetes

2. Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients

3. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors

4. New insights into the mode of action of anti-inflammatory drugs

5. Use of NSAIDs in treating patients with arthritis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NSAID: Current limits to prescription;Joint Bone Spine;2024-07

2. A systematic review: Sinomenine;Heliyon;2024-05

3. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Duhuo–Jisheng pair against osteoarthritis;Journal of Pharmacy and Pharmacology;2024-01-06

4. Secoisolariciresinol diglucoside Ameliorates Osteoarthritis via Nuclear factor-erythroid 2-related factor-2/ nuclear factor kappa B Pathway: In vitro and in vivo experiments;Biomedicine & Pharmacotherapy;2023-08

5. Novel Formulation Approaches used for the Management of Osteoarthritis: A Recent Review;Current Drug Delivery;2023-08